FUND THE PRIZE! A competition using technology and open science to accelerate a cure for ALS.
Scoop.it!
No comment yet.
Sign up to comment
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
#ALS AWARENESS #LouGehrigsDisease #PARKINSONS
158.1K views |
+0 today
Raising ALS | Lou Gehrigs Disease & Parkinsons Disease AWARENESS to the NEXT LEVEL!
 Your new post is loading...
Your new post is loading...
Scoop.it!
Scoop.it!
Before diving too deeply into this story on Lou Gehrig’s disease research, you should know about a technique that manipulates an adult’s blood or skin cell into behaving like an embryonic stem cell.
Scoop.it!
Using a technique that illuminates subtle changes in individual proteins, chemistry researchers at Cornell University have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis (ALS).
Jade Nicole Burman's curator insight,
October 29, 2014 11:03 AM
Your donations are helping ! ALS moved forward with their research and began figuring out the causes of ALS, and that's one step closer to finding a cure! Way to go guys, keep it up! #ALSAwareness
Scoop.it!
CBS News looks into the state of ALS research amid the success of the Ice Bucket Challenge and the millions of dollars donated to fight the disease
Scoop.it!
A series of studies begun by Harvard Stem Cell Institute (HSCI) scientists eight years ago has lead to a report just published that may be a major step forward in the quest to develop real...
Scoop.it!
Could a key ingredient in a children’s toy play a role in better treating neurological disorders such as Lou Gehrig’s, Huntington’s, and Alzheimer’s disease?RELATED CONTENTStem Cells May Help Heal Diseased KidneysScientists Create Embryonic-Type Stem Cells Without Embryos
Scoop.it!
Leonard Petrucelli, chair of the department of Neuroscience at the Mayo Clinic in Jacksonville, has received a 2013 Amyotrophic Lateral Sclerosis Research Program’s investigator-initiated award, which focuses on the discovery and validation of ALS biomarkers. ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. There is no cure and no life-prolonging treatments for the disease. The Amyotrophic Lateral Sclerosis Research Program is a............
Danielle Christian's curator insight,
December 6, 2021 8:24 PM
the more research done into ALS will have better outcomes for those diagnosed
Scoop.it!
Scientists believe that may have discovered the origin of Lou Gehrig's disease. This discovery can be used to better understand how the disease works in efforts to develop better treatment and possibly even a cure one day.
Scoop.it!
|
Scoop.it!
In most cases of Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), it's not known what caused the condition, but a new study finds genes may play a larger role than previously thought.
Scoop.it!
Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, attacks muscle-controlling nerve cells – motor neurons – in the brain, brainstem
Scoop.it!
Northwestern Medicine scientists identified the same protein deposits that are usually found in the brains of ALS patients in the retina, opening a new potential avenue for diagnosing and tracking the disease.
Scoop.it!
An international team of scientists is experimenting with a potential drug to block the production of a protein linked to amyotrophic lateral sclerosis.
Scoop.it!
With help from the ALS Association, NEALS provides up-to-date information for finding both federally and privately funded clinical studies focusing on ALS and motor neuron diseases. You can locate both interventional trials, which examine if treatments are effective and safe under controlled environments, and observation trials, which examine people in more natural environments.
Scoop.it!
Read about how the Phase 1 Trial for ALS Results of Novel Stem-Cell Therapy Presented By Neuralstem Representative.
Scoop.it!
The Cedars-Sinai Regenerative Medicine Institute has received a $2.5 million grant from the Department of Defense to conduct animal studies that, if successful, could provide the basis for a clinical trial of a gene therapy product for patients with Lou Gehrig's disease, also called amyotrophic lateral sclerosis, or ALS.
Scoop.it!
An antioxidant discovered more than a dozen years ago may be able to treat patients with amyotrophic lateral sclerosis, a devastating neurodegenerative disease that is usually fatal within 5 years of diagnosis that currently has no cure.
Danielle Christian's curator insight,
December 6, 2021 8:23 PM
ALS can be slowed with a simple antioxidant
Scoop.it!
Investigators were able to use astrocytes grown from amyotrophic lateral sclerosis (ALS) patients' post-mortem cerebral cortex and/or spinal cord samples and human embryonic stem cell-derived motor neurons to create a novel model for sporadic ALS. The technique......
Scoop.it!
The US Food and Drug Administration–approved trial, “A Phase 1, Open-Label, First-in-Human, Feasibility and Safety Study of Human Spinal Cord-Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis, Protocol Number: NS2008-1,” is complete. Our overall objective was to .............
Scoop.it!
UBC researchers have found how the devastating disease ALS, also known as Lou Gehrig's disease, spreads -- and say transmission can be blocked.
|
